Estabrook Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.63M | Sell |
18,847
-45
| -0.2% | -$16K | 0.97% | 32 |
|
|
2025
Q4 | $6.18M | Sell |
18,892
-428
| -2% | -$136K | 0.91% | 34 |
|
|
2025
Q3 | $5.45M | Sell |
19,320
-184
| -0.9% | -$53.4K | 0.79% | 38 |
|
|
2025
Q2 | $5.45M | Sell |
19,504
-220
| -1% | -$62.3K | 0.84% | 35 |
|
|
2025
Q1 | $6.15M | Sell |
19,724
-581
| -3% | -$172K | 0.99% | 33 |
|
|
2024
Q4 | $5.29M | Sell |
20,305
-110
| -0.5% | -$32.6K | 0.82% | 36 |
|
|
2024
Q3 | $6.58M | Sell |
20,415
-317
| -2% | -$104K | 0.98% | 31 |
|
|
2024
Q2 | $6.48M | Sell |
20,732
-322
| -2% | -$94.6K | 1% | 28 |
|
|
2024
Q1 | $5.99M | Sell |
21,054
-344
| -2% | -$101K | 0.92% | 32 |
|
|
2023
Q4 | $6.16M | Sell |
21,398
-172
| -0.8% | -$46.9K | 1.01% | 30 |
|
|
2023
Q3 | $5.8M | Sell |
21,570
-67
| -0.3% | -$16.7K | 1.02% | 29 |
|
|
2023
Q2 | $4.8M | Sell |
21,637
-131
| -0.6% | -$30.4K | 0.8% | 35 |
|
|
2023
Q1 | $5.26M | Sell |
21,768
-149
| -0.7% | -$36.6K | 0.91% | 32 |
|
|
2022
Q4 | $5.76M | Sell |
21,917
-1,045
| -5% | -$280K | 0.99% | 33 |
|
|
2022
Q3 | $5.18M | Sell |
22,962
-40
| -0.2% | -$9.7K | 0.96% | 33 |
|
|
2022
Q2 | $5.6M | Sell |
23,002
-536
| -2% | -$131K | 0.96% | 30 |
|
|
2022
Q1 | $5.69M | Sell |
23,538
-257
| -1% | -$59K | 0.84% | 34 |
|
|
2021
Q4 | $5.35M | Sell |
23,795
-443
| -2% | -$93.5K | 0.76% | 34 |
|
|
2021
Q3 | $5.15M | Sell |
24,238
-536
| -2% | -$123K | 0.81% | 34 |
|
|
2021
Q2 | $6.04M | Sell |
24,774
-797
| -3% | -$196K | 0.92% | 32 |
|
|
2021
Q1 | $6.36M | Sell |
25,571
-109
| -0.4% | -$26K | 0.98% | 29 |
|
|
2020
Q4 | $5.9M | Sell |
25,680
-43
| -0.2% | -$9.91K | 0.98% | 29 |
|
|
2020
Q3 | $6.54M | Sell |
25,723
-709
| -3% | -$176K | 1.2% | 26 |
|
|
2020
Q2 | $6.23M | Sell |
26,432
-1,819
| -6% | -$415K | 1.18% | 29 |
|
|
2020
Q1 | $5.73M | Sell |
28,251
-2,499
| -8% | -$546K | 1.21% | 27 |
|
|
2019
Q4 | $7.41M | Sell |
30,750
-1,421
| -4% | -$313K | 1.11% | 29 |
|
|
2019
Q3 | $6.23M | Sell |
32,171
-928
| -3% | -$178K | 1.04% | 31 |
|
|
2019
Q2 | $6.1M | Sell |
33,099
-578
| -2% | -$103K | 1% | 33 |
|
|
2019
Q1 | $6.4M | Buy |
33,677
+454
| +1% | +$86.7K | 1.06% | 32 |
|
|
2018
Q4 | $6.47M | Sell |
33,223
-2,620
| -7% | -$511K | 1.2% | 30 |
|
|
2018
Q3 | $7.43M | Sell |
35,843
-848
| -2% | -$167K | 1.12% | 29 |
|
|
2018
Q2 | $6.77M | Sell |
36,691
-3,651
| -9% | -$646K | 1.07% | 33 |
|
|
2018
Q1 | $6.88M | Buy |
40,342
+47
| +0.1% | +$8.63K | 1.08% | 31 |
|
|
2017
Q4 | $7.01M | Sell |
40,295
-100
| -0.2% | -$17.7K | 1.06% | 33 |
|
|
2017
Q3 | $7.53M | Sell |
40,395
-659
| -2% | -$117K | 1.17% | 31 |
|
|
2017
Q2 | $7.07M | Sell |
41,054
-234
| -0.6% | -$38.1K | 1.13% | 33 |
|
|
2017
Q1 | $6.77M | Buy |
41,288
+2,089
| +5% | +$347K | 1.06% | 36 |
|
|
2016
Q4 | $5.73M | Sell |
39,199
-10,956
| -22% | -$1.65M | 0.9% | 39 |
|
|
2016
Q3 | $8.37M | Buy |
50,155
+2,777
| +6% | +$470K | 1.23% | 32 |
|
|
2016
Q2 | $7.21M | Buy |
47,378
+9,489
| +25% | +$1.48M | 1.08% | 38 |
|
|
2016
Q1 | $5.68M | Sell |
37,889
-832
| -2% | -$124K | 0.84% | 40 |
|
|
2015
Q4 | $6.29M | Sell |
38,721
-2,179
| -5% | -$343K | 0.91% | 38 |
|
|
2015
Q3 | $5.66M | Sell |
40,900
-1,599
| -4% | -$252K | 0.82% | 39 |
|
|
2015
Q2 | $6.52M | Buy |
42,499
+812
| +2% | +$130K | 0.81% | 39 |
|
|
2015
Q1 | $6.66M | Buy |
41,687
+39,017
| +1,461% | +$6.14M | 0.78% | 40 |
|
|
2014
Q4 | $425K | Hold |
2,670
| – | – | 0.05% | 120 |
|
|
2014
Q3 | $375K | Hold |
2,670
| – | – | 0.04% | 130 |
|
|
2014
Q2 | $316K | Hold |
2,670
| – | – | 0.03% | 145 |
|
|
2014
Q1 | $329K | Hold |
2,670
| – | – | 0.03% | 142 |
|
|
2013
Q4 | $305K | Hold |
2,670
| – | – | 0.03% | 150 |
|
|
2013
Q3 | $299K | Hold |
2,670
| – | – | 0.03% | 150 |
|
|
2013
Q2 | $263K | Buy |
+2,670
| New | +$277K | 0.03% | 155 |
|
Other funds holding AMGN
VCM
VPM
Estabrook Capital Management's AMGN Position: Q1 2026 in Review
Estabrook Capital Management reduced its Amgen (AMGN) stake by 0.24% in Q1 2026, selling an estimated $16K and leaving 18,847 shares worth $6.63M. The position accounts for 0.97% of the portfolio, ranked #32.
Estabrook Capital Management first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.37M in Q3 2016. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Estabrook Capital Management held 18,847 shares of Amgen worth $6.63M as of Q1 2026.
- Estabrook Capital Management sold 45 Amgen shares in Q1 2026, an estimated $16K.
- Amgen made up 0.97% of Estabrook Capital Management's portfolio in Q1 2026, its #32 holding.
- Estabrook Capital Management first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Estabrook Capital Management's Amgen position peaked at $8.37M in Q3 2016.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Estabrook Capital Management's 13F filing for Q1 2026, filed 14 May 2026.